Avila Therapeutics

Avila Therapeutics is a biotechnology company focused on the development of covalent drugs to treat cancer and other autoimmune diseases.

Business Model:

Revenue: $0

Employees: 11-50

Rankings

Detailed Avila Therapeutics Information

Avila Therapeutics was acquired by Celgene.
The acquisition happend on 2012-01-26.
Details of the transaction were not public

Acquirer

Geographic Data

Avila Therapeutics headquarters map

Address:

City: Waltham

State: Massachusetts

Zip:

Country: United States

Financial Info

Stage:

series unknown

Raised Last:

$20M

Raised Total:

$59M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Avila Therapeutics designs and develops covalent drugs for viral infections, cancers, and autoimmune diseases. It offers AVL-181, a small molecule hepatitis C virus protease inhibitor. Avila Therapeutics has a strategic alliance with Sanofi-Aventis. The company was incorporated in 2006 and is based in Waltham, Massachusetts. As of March 7, 2012, Avila Therapeutics operates as a subsidiary of Celgene Corporation.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research